| 000 | 01014 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250510212310.0 | ||
| 264 | 0 | _c19800324 | |
| 008 | 198003s 0 0 eng d | ||
| 022 | _a0301-5149 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLotte, A | |
| 245 | 0 | 0 |
_aBalance of risks and balance of costs regarding tuberculosis and antituberculous vaccination. _h[electronic resource] |
| 260 |
_bDevelopments in biological standardization _c1979 |
||
| 300 |
_a111-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBCG Vaccine _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aTuberculosis _xeconomics |
| 650 | 0 | 4 |
_aVaccination _xadverse effects |
| 700 | 1 | _aWasz-Höckert, O | |
| 700 | 1 | _aLert, F | |
| 700 | 1 | _aDumitrescu, N | |
| 700 | 1 | _aPoisson, N | |
| 773 | 0 |
_tDevelopments in biological standardization _gvol. 43 _gp. 111-9 |
|
| 999 |
_c115864 _d115864 |
||